International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy.
暂无分享,去创建一个
Pierre I Karakiewicz | Hartwig Huland | Markus Graefen | Robert L Sutherland | Susan M Henshall | Eric Klein | Michael W Kattan | Ilias Cagiannos | Andreas Erbersdobler | Alexander Haese | T. H. van der Kwast | M. Kattan | P. Scardino | J. Eastham | A. Haese* | E. Klein | B. Bochner | M. Graefen | H. Huland | P. Karakiewicz | P. Kupelian | R. Sutherland | S. Henshall | P. Stricker | J. Grygiel | I. Cagiannos | T. Cangiano | D. Skinner | A. Erbersdobler | D. Quinn | Peter T Scardino | David I Quinn | John J Grygiel | Phillip D Stricker | Patrick Kupelian | Donald G Skinner | Gary Lieskovsky | Bernard Bochner | Peter G Hammerer | James A Eastham | Jean de Kernion | Thomas Cangiano | Fritz H Schröder | Mark F Wildhagen | Theo H van der Kwast | G. Lieskovsky | P. Hammerer | M. Wildhagen | J. D. De Kernion | F. Schröder | F. Schröder
[1] Lloyd D. Fisher,et al. Biostatistics: A Methodology for the Health Sciences , 1993 .
[2] M W Kattan,et al. Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] J. Blasko,et al. Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer. , 2001, Urology.
[4] F. Harrell,et al. Evaluating the yield of medical tests. , 1982, JAMA.
[5] Jesse A. Berlin,et al. Assessing the Generalizability of Prognostic Information , 1999 .
[6] W. Catalona,et al. Artificial neural networks in the diagnosis and prognosis of prostate cancer: a pilot study. , 1994, The Journal of urology.
[7] A. Renshaw,et al. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Thomas M. Wheeler,et al. A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer , 1998 .
[9] A. Haese*,et al. Early Prostate-Specific Antigen Relapse after Radical Retropubic Prostatectomy:Prediction on the Basis of Preoperative andPostoperative Tumor Characteristics , 1999, European Urology.
[10] C. Begg,et al. Comparing tumour staging and grading systems: a case study and a review of the issues, using thymoma as a model. , 2000, Statistics in medicine.
[11] A W Partin,et al. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. , 2000, The Journal of urology.
[12] D. Chan,et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. , 1993, The Journal of urology.
[13] A. Renshaw,et al. Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.